Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.58 – $1.31
51% from low
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $2.9M | $2.1M | $2.1M | $1.7M | $1.6M | $2.3M | $2.4M |
| Cost of revenue | $368.0K | $650.0K | $628.0K | $832.0K | $684.0K | $936.0K | $1.3M | $7.6M |
| Gross profit | $3.5M | $2.2M | $1.5M | $1.2M | $983.0K | $662.0K | $1.0M | −$5.2M |
| Gross margin | 90.4% | 77.3% | 70.1% | 59.5% | 59.0% | 41.4% | 44.5% | -211.1% |
| R&D | $110.0K | $0 | $0 | $0 | $3.1M | $0 | $0 | $4.3M |
| Operating income | −$1.6M | −$4.7M | −$9.1M | −$8.6M | −$9.4M | −$15.3M | −$12.0M | −$11.7M |
| EBITDA | −$1.9M | −$4.5M | −$8.8M | −$6.4M | −$7.7M | −$14.0M | −$12.0M | −$11.4M |
| Net income | −$2.5M | −$4.9M | −$9.1M | −$8.8M | −$11.3M | −$15.7M | −$15.4M | −$47.7M |
| Net margin | -64.8% | -169.5% | -433.0% | -428.1% | -674.9% | -980.1% | -673.8% | -1953.0% |
| EPS (diluted) | -0.01 | -0.02 | -0.04 | -0.03 | -0.04 | -0.06 | -0.06 | -0.16 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3M | $-0.03 | $-0.03–$-0.03 | 1 |
| 2027 | $14M | $0.00 | $0.00–$0.00 | 0 |
| 2028 | $48M | $0.07 | $0.07–$0.07 | 1 |
| 2029 | $137M | $0.20 | $0.20–$0.20 | 1 |
Forward consensus · source: Financial Modeling Prep
SPECTRAL MEDICAL INC ORD
No one on the platform currently holds EDTXF.
No tracked institution reports a position in EDTXF as of their last filing.
No one on the platform has traded EDTXF yet.
| $321M |
| — |
| DMTRF3-D Matrix, Ltd. | $2.25 | +0.00% | $270M | — |
| FGHQFFrontage Holdings Corporation | $0.14 | +0.00% | $274M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 121.5× sales vs its 46.5× historical median P/S.
Fair value ≈ $0.36 · price $0.95 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.